Cotinga Pharmaceuticals Inc (COTQF)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Cotinga Pharmaceuticals Total Assets (Quarterly): 0.6885M for Jan. 31, 2020
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2020 | 0.6885M |
| October 31, 2019 | 0.7159M |
| July 31, 2019 | 0.7644M |
| April 30, 2019 | 0.9277M |
| January 31, 2019 | 1.054M |
| October 31, 2018 | 1.098M |
| July 31, 2018 | 1.549M |
| April 30, 2018 | 1.193M |
| January 31, 2018 | 1.562M |
| October 31, 2017 | 2.308M |
| July 31, 2017 | 2.067M |
| April 30, 2017 | 2.954M |
| January 31, 2017 | 4.160M |
| October 31, 2016 | 4.895M |
| July 31, 2016 | 5.704M |
| April 30, 2016 | 5.466M |
| January 31, 2016 | 2.587M |
| October 31, 2015 | 3.117M |
| July 31, 2015 | 3.519M |
| April 30, 2015 | 2.905M |
| January 31, 2015 | 3.087M |
| October 31, 2014 | 2.147M |
| July 31, 2014 | 2.351M |
| April 30, 2014 | 2.307M |
| January 31, 2014 | 1.971M |
| Date | Value |
|---|---|
| October 31, 2013 | 2.692M |
| July 31, 2013 | 2.199M |
| April 30, 2013 | 2.23M |
| January 31, 2013 | 2.664M |
| October 31, 2012 | 2.770M |
| July 31, 2012 | 3.386M |
| April 30, 2012 | 4.228M |
| January 31, 2012 | 3.076M |
| October 31, 2011 | 3.730M |
| July 31, 2011 | 4.290M |
| April 30, 2011 | 4.948M |
| January 31, 2011 | 3.109M |
| October 31, 2010 | 3.572M |
| July 31, 2010 | 4.039M |
| April 30, 2010 | 4.749M |
| January 31, 2010 | 4.246M |
| October 31, 2009 | 4.828M |
| July 31, 2009 | 5.579M |
| April 30, 2009 | 5.792M |
| January 31, 2009 | 6.395M |
| October 31, 2008 | 7.114M |
| July 31, 2008 | 9.161M |
| April 30, 2008 | 9.616M |
| January 31, 2008 | 10.64M |
| October 31, 2007 | 3.648M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.6885M
Minimum
Jan 2020
0.7644M
Maximum
Jul 2019
0.7229M
Average
0.7159M
Median
Oct 2019
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Liminal Biosciences Inc (DELISTED) | 23.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.642M |
| Shareholders Equity (Quarterly) | -2.954M |